Literature DB >> 7053211

In vitro demonstration of in situ autologous tumour-cell cytotoxicity in MSV-induced tumours in A/SN mice.

S Becker, S Haskill.   

Abstract

Moloney sarcoma-virus (MSV)-induced tumours in A/Sn mice have been dispersed with collagenase and DNase 8-15 days after virus inoculation, and both "sarcoma" and inflammatory cells separated by sedimentation velocity and adherence techniques. The isolated "sarcoma" cells had the morphological characteristics of atypical cells (i.e. cytoplasmic blebbing, vacuolization and prominent nucleoli) and were easily adapted to in vitro growth. As few as 2 x 10(3) of these cells inoculated i.m. produced new tumours within 8 days of injection in both syngeneic and allogeneic mice. Also, cell-free supernatant from "sarcoma"-cell cultures produced tumours, indicating that the successful transplantation of the "sarcoma" cells was probably due to production of infective virus. Cells cytotoxic in vitro against the "sarcoma" cells were present within both spleen and tumour of the tumour donors, but not in the spleens of normal mice. The cytotoxicity was specific against virus-infected cells, since in a mixture of virus-positive (gp 70) and virus-negative cells, positive cells were removed while negative cells were not affected, as measured by a visual cytotoxicity assay using immunostaining. Although T cells could be isolated from the MSV-induced tumours, these cells did not appear to mediate the cytotoxicity detected against the MSV "sarcoma" cells. These results suggest that early MSV infections might be sensitive to cytotoxic mechanisms distinct from those reported with established MLV- or MSV-induced tumour lines.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7053211      PMCID: PMC2010615          DOI: 10.1038/bjc.1981.46

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  Pathologic and virologic studies of tumors induced in mice by two strains of murine sarcoma virus.

Authors:  P J Simons; D J McCully
Journal:  J Natl Cancer Inst       Date:  1970-06       Impact factor: 13.506

2.  Delayed tumour appearance and absence of regression in nude mice infected with murine sarcoma virus.

Authors:  O Stutman
Journal:  Nature       Date:  1975-01-10       Impact factor: 49.962

3.  Evidence for in vivo protection against murine-sarcoma virus-induced tumors by T lymphocytes from immune animals.

Authors:  R M Gorczynski
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

4.  Studies on Murine Sarcoma Virus; a morphological comparison of tumorigenesis by the Harvey and Moloney strains in mice, and the establishment of tumor cell lines.

Authors:  L D Berman; A C Allison
Journal:  Int J Cancer       Date:  1969-11-15       Impact factor: 7.396

5.  Immune paralysis of thymus cells by bovine serum albumin.

Authors:  R B Taylor
Journal:  Nature       Date:  1968-11-09       Impact factor: 49.962

6.  An immunoglobulin-enzyme bridge method for localizing tissue antigens.

Authors:  T E Mason; R F Phifer; S S Spicer; R A Swallow; R B Dreskin
Journal:  J Histochem Cytochem       Date:  1969-09       Impact factor: 2.479

7.  Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. II. Morphologic studies.

Authors:  M F Stanton; L W Law; R C Ting
Journal:  J Natl Cancer Inst       Date:  1968-05       Impact factor: 13.506

8.  Pathogenesis of virus-induced murine sarcoma. I. Light microscopy.

Authors:  R Siegler
Journal:  J Natl Cancer Inst       Date:  1970-07       Impact factor: 13.506

9.  Separation of cells by velocity sedimentation.

Authors:  R G Miller; R A Phillips
Journal:  J Cell Physiol       Date:  1969-06       Impact factor: 6.384

10.  Pathogenesis of a virus-induced rhabdomyosarcoma in mice.

Authors:  K Perk; J B Moloney
Journal:  J Natl Cancer Inst       Date:  1966-11       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.